Loading...
NPI 1093274680 · Tarrytown, NY · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Bridge Dermatopathology Services PLLC is a clinical medical laboratory provider located in Tarrytown, New York. This profile covers 12 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Bridge Dermatopathology Services PLLC |
| Address | 560 White Plains Rd Fl 6 |
| City | Tarrytown |
| State | NY |
| ZIP | 10591 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 13, 2019 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4.3M |
| Medicaid | $762.7K |
Specialty/service-line: The provider’s billing mix is concentrated in surgical pathology and dermatopathology workflows, with 88305 (level IV surgical pathology) as the clear core service ($3.8M revenue on Medicare and $665.1K on Medicaid). Ancillary pathology procedures such as single-antibody immunostains (for example 88350, 88341, 88342) and select special stains/ISH (for example 88312, 88365) appear in the mix but contribute only a small share of revenue compared with primary surgical pathology interpretation.
Medicare revenue concentration: Lifetime Medicare revenue is $4.3M and the top three Medicare codes account for 93.6% of that total, driven overwhelmingly by 88305 which alone generated $3.8M (89.1% of this provider's Medicare revenue). This indicates a very high dependence on a single high-level surgical pathology code for Medicare payment.
Medicaid revenue concentration: Lifetime Medicaid revenue is $762.7K and the top three Medicaid codes account for 99.9% of that total, with 88305 again dominant at $665.1K (86.4% of Medicaid revenue). Medicaid billing is even more concentrated in the same surgical pathology codes as Medicare, suggesting the same core service lines drive nearly all payer revenue.
Payer mix and scale: Medicare ($4.3M) is the dominant payer by scale relative to Medicaid ($762.7K), making Medicare the principal revenue source for this provider. Both payers, however, show the same operational focus on high-level surgical pathology coding rather than a broad multi-service revenue portfolio.
Competitive standing — Medicare national: For 88305 the provider ranks #11 of 14580 nationally (100th percentile; extreme outlier), and for 88304 ranks #9 of 8796 (100th percentile; extreme outlier), indicating this entity is an unusually large national-volume biller for core surgical pathology codes and operates well above typical provider volume for those services. Other Medicare codes (for example 88350 at rank #38 of 652 and 88312 at rank #215 of 6966) fall into high percentiles but are described as typical or unremarkable in volume.
Competitive standing — Medicaid in-state: For Medicaid 88305 the provider ranks #15 of 642 in-state (98th percentile; notably above typical state volume), indicating a strong statewide presence for the primary surgical pathology service. The follow-on Medicaid codes 88304 and 88312 rank in the 94th and 87th percentiles respectively, consistent with a prominent but narrowly focused state-level operation.
Operational risk/profile: The combination of extremely high rank and narrow code concentration (top three Medicare codes = 93.6% of Medicare revenue; top three Medicaid codes = 99.9% of Medicaid revenue) indicates revenue concentration risk tied to demand and reimbursement for a small set of surgical pathology services. If referral patterns or reimbursement for those core codes change, overall revenue would likely be materially affected given the current billing profile.
Tenure and registration: The provider NPI was enumerated on 2019-03-13 (~7 years ago), indicating several years of active billing history under this registration, during which it established a high-volume presence in surgical pathology codes across Medicare and Medicaid.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 62,750 | $60 | $3.8M |
| 88350 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. Code +88350 describes… | 980 | $110 | $104.3K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 900 | $100 | $90.9K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2,150 | $40 | $81.7K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 870 | $80 | $68.7K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 620 | $90 | $55K |
| 88346 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. | 250 | $140 | $33.6K |
| 88365 | The lab analyst applies an initial in situ hybridization single probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 80 | $160 | $13K |
| 88364 | The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. Then a… | 80 | $120 | $9.2K |
| 88321 | A qualified provider, typically a pathologist, provides consultation and a report on slides prepared elsewhere. A unit of service is the surgical case regardless of the number of slides received. | 70 | $90 | $6.2K |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 28,920 | $20 | $665.1K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 4,290 | $10 | $60.1K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 2,460 | $20 | $44.2K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 40 | $20 | $780 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 15 | 640 | 1,080 | $60 | $251.5K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 35 | 260 | 310 | $80 | $112.4K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 287 | 340 | 510 | $50 | $80K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 16 | 260 | 450 | $20 | $28.7K |
Other providers in the same ZIP code as Bridge Dermatopathology Services PLLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Ent And Allergy Associates LLP | NY | Otolaryngology Physician | $0 | $117.8M |
| Family Home Health Care Inc | NY | Home Health Agency | $0 | $58.5M |
| Phelps Memorial Hospital Association | NY | General Acute Care Hospital | $0 | $20.2M |
| Cameron Budenz | NY | Otology & Neurotology Physician | $110.7K | $11.3M |
| Brian Gruber | NY | Physician Assistant | $523.2K | $0 |
| Jozef Debiec | NY | Interventional Pain Medicine Physician | $514K | $0 |
| Robert Shirinov | NY | Surgery Physician | $390.4K | $52.9K |
| Joseph Castellano | NY | Ophthalmology Physician | $71.6K | $367.6K |
| Deya Jourdy | NY | Otolaryngology Physician | $402.6K | $2.2K |
| Craig Zalvan | NY | Otolaryngology Physician | $401.4K | $750 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.